Clinical presentation, microbiological aetiology and disease course in patients with flu-like illness: a post hoc analysis of randomised controlled trial data.
Authors
Verheij, Theo JCianci, Daniela
van der Velden, Alike W
Butler, Christopher C
Bongard, Emily
Coenen, Samuel
Colliers, Annelies
Francis, Nick A
Little, Paul
Godycki-Cwirko, Maciek
Llor, Carl
Chlabicz, Sławomir
Lionis, Christos
Sundvall, Pär-Daniel
Bjerrum, Lars
De Sutter, An
Aabenhus, Rune
Harbin, Nicolay Jonassen
Lindbæk, Morten
Glinz, Dominik
Bucher, Heiner C
Kovács, Bernadett
Seifert, Bohumil
Jurgute, Ruta Radzeviciene
Lundgren, Pia Touboul
de Paor, Muireann
Matheeussen, Veerle
Goossens, Herman
Ieven, Margareta
Issue Date
2022-02-24Keywords
DIAGNOSISoseltamivir
primary health care
randomised controlled trial
respiratory tract infections
Metadata
Show full item recordJournal
The British journal of general practice : the journal of the Royal College of General PractitionersDOI
10.3399/BJGP.2021.0344PubMed ID
34990385Item Type
ArticleLanguage
enEISSN
1478-5242ae974a485f413a2113503eed53cd6c53
10.3399/BJGP.2021.0344
Scopus Count
Collections
The following license files are associated with this item:
- Creative Commons
Related articles
- Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
- Authors: Emadi A, Chua JV, Talwani R, Bentzen SM, Baddley J
- Issue date: 2020 Oct 28
- Lower respiratory tract infection in the community: associations between viral aetiology and illness course.
- Authors: Vos LM, Bruyndonckx R, Zuithoff NPA, Little P, Oosterheert JJ, Broekhuizen BDL, Lammens C, Loens K, Viveen M, Butler CC, Crook D, Zlateva K, Goossens H, Claas ECJ, Ieven M, Van Loon AM, Verheij TJM, Coenjaerts FEJ, GRACE Consortium
- Issue date: 2021 Jan
- Did aetiology matter in illness duration and complications in patients presenting in primary care with acute respiratory tract infections early in the COVID-19 pandemic: An observational study in nine countries.
- Authors: Venekamp RP, Eijkemans MJC, Zuithoff NPA, Böhmer F, Chlabicz S, Colliers A, García-Sangenís A, Malania L, Pauer J, Tomacinschii A, Verheij TJ, Goossens H, Vellinga A, Butler CC, van der Velden AW
- Issue date: 2024 Dec
- Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial.
- Authors: González R, García-Otero L, Pons-Duran C, Marbán-Castro E, Goncé A, Llurba E, Gil MDM, Rodríguez-Zambrano MÁ, Chen H, Ramírez M, Bardají A, Menendez C
- Issue date: 2020 Jul 2
- SPIKE-1: A Randomised Phase II/III trial in a community setting, assessing use of camostat in reducing the clinical progression of COVID-19 by blocking SARS-CoV-2 Spike protein-initiated membrane fusion.
- Authors: Halford S, Wan S, Dragoni I, Silvester J, Nazarov B, Anthony D, Anthony S, Ladds E, Norrie J, Dhaliwal K, CDD SPIKE-1 Project Team
- Issue date: 2021 Aug 19